COMP <GO>
AGL vs PGNY // RETURN ON INVESTED CAPITAL (ROIC)
agilon health inc. (NYSE) VS. Progyny Inc. (NASDAQ) • 15-METRIC TALLY: AGL 0
— PGNY 9
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: PGNY
LAST: $85.94 (-5.56%) • MKT CAP: $1.44B
roic
-35.00%
LAST: $28.40 (+1.90%) • MKT CAP: $2.18B
roic
16.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AGL VS. PGNY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AGL | PGNY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 23.60% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 16.70% | -51.70 | PGNY | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 20.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.25% | 8.80% | -17.05 | PGNY | /fcf-yield <GO> |
| Operating Margin | -7.80% | 6.60% | -14.40 | PGNY | /operating-margins <GO> |
| Net Profit Margin | -6.60% | 4.50% | -11.10 | PGNY | /net-margins <GO> |
| Revenue Growth (YoY) | -2.10% | 10.40% | -12.50 | PGNY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.06 | 8.84 | -6.78 | PGNY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | PGNY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 46.4 | 55.1 | -8.70 | PGNY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 34.6x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.44B | $2.18B | -$736.0M | PGNY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AGL REV | PGNY REV | AGL GROSS % | PGNY GROSS % | AGL FCF | PGNY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.93B | $1.29B | — | 23.6% | -$119.0M | $191.8M |
| FY 2024 | $6.06B | $1.17B | — | 21.7% | -$71.0M | $173.7M |
| FY 2023 | $4.32B | $1.09B | — | — | -$156.2M | $188.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AGL // BETA —
PGNY // BETA —